These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 24931457)

  • 1. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease.
    Dhillon SS; Fattouh R; Elkadri A; Xu W; Murchie R; Walters T; Guo C; Mack D; Huynh HQ; Baksh S; Silverberg MS; Griffiths AM; Snapper SB; Brumell JH; Muise AM
    Gastroenterology; 2014 Sep; 147(3):680-689.e2. PubMed ID: 24931457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
    Morel F
    Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2.
    Muise AM; Xu W; Guo CH; Walters TD; Wolters VM; Fattouh R; Lam GY; Hu P; Murchie R; Sherlock M; Gana JC; ; Russell RK; Glogauer M; Duerr RH; Cho JH; Lees CW; Satsangi J; Wilson DC; Paterson AD; Griffiths AM; Silverberg MS; Brumell JH
    Gut; 2012 Jul; 61(7):1028-35. PubMed ID: 21900546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome.
    Falcone EL; Abusleme L; Swamydas M; Lionakis MS; Ding L; Hsu AP; Zelazny AM; Moutsopoulos NM; Kuhns DB; Deming C; Quiñones M; Segre JA; Bryant CE; Holland SM
    Microbiome; 2016 Apr; 4():13. PubMed ID: 27044504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
    Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
    Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
    Condino-Neto A; Newburger PE
    Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the membrane topology of the phagocyte NADPH oxidase: characterization of an anti-gp91-phox conformational monoclonal antibody.
    Campion Y; Paclet MH; Jesaitis AJ; Marques B; Grichine A; Berthier S; Lenormand JL; Lardy B; Stasia MJ; Morel F
    Biochimie; 2007 Sep; 89(9):1145-58. PubMed ID: 17397983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down-regulating expression of genes encoding oxidase components.
    Condino-Neto A; Whitney C; Newburger PE
    J Immunol; 1998 Nov; 161(9):4960-7. PubMed ID: 9794432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and biochemical background of chronic granulomatous disease.
    Jurkowska M; Bernatowska E; Bal J
    Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel CYBB Mutation in Chronic Granulomatous Disease in Iran.
    Tajik S; Badalzadeh M; Fazlollahi MR; Houshmand M; Zandieh F; Khandan S; Pourpak Z
    Iran J Allergy Asthma Immunol; 2016 Oct; 15(5):426-429. PubMed ID: 27917630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in NADPH Oxidase Genes
    Hayes P; Dhillon S; O'Neill K; Thoeni C; Hui KY; Elkadri A; Guo CH; Kovacic L; Aviello G; Alvarez LA; Griffiths AM; Snapper SB; Brant SR; Doroshow JH; Silverberg MS; Peter I; McGovern DP; Cho J; Brumell JH; Uhlig HH; Bourke B; Muise AA; Knaus UG
    Cell Mol Gastroenterol Hepatol; 2015 Sep; 1(5):489-502. PubMed ID: 26301257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminal flavin domain of gp91phox bound to plasma membranes of granulocyte-like X-CGD PLB-985 cells is sufficient to anchor cytosolic oxidase components and support NADPH oxidase-associated diaphorase activity independent of cytosolic phospholipase A2 regulation.
    Pessach I; Shmelzer Z; Leto TL; Dinauer MC; Levy R
    J Leukoc Biol; 2006 Sep; 80(3):630-9. PubMed ID: 16844764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
    Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
    J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation.
    Green SP; Cairns B; Rae J; Errett-Baroncini C; Hongo JA; Erickson RW; Curnutte JT
    J Cereb Blood Flow Metab; 2001 Apr; 21(4):374-84. PubMed ID: 11323523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
    Li Q; Lee CH; Peters LA; Mastropaolo LA; Thoeni C; Elkadri A; Schwerd T; Zhu J; Zhang B; Zhao Y; Hao K; Dinarzo A; Hoffman G; Kidd BA; Murchie R; Al Adham Z; Guo C; Kotlarz D; Cutz E; Walters TD; Shouval DS; Curran M; Dobrin R; Brodmerkel C; Snapper SB; Klein C; Brumell JH; Hu M; Nanan R; Snanter-Nanan B; Wong M; Le Deist F; Haddad E; Roifman CM; Deslandres C; Griffiths AM; Gaskin KJ; Uhlig HH; Schadt EE; Muise AM
    Gastroenterology; 2016 May; 150(5):1196-1207. PubMed ID: 26836588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAPDH Oxidases in Inflammatory Bowel Disease.
    Stenke E; Bourke B; Knaus UG
    Methods Mol Biol; 2019; 1982():695-713. PubMed ID: 31172500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
    Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
    J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional characterization of two novel mutations in the α-helical loop (residues 484-503) of CYBB/gp91(phox) resulting in the rare X91(+) variant of chronic granulomatous disease.
    Boog B; Quach A; Costabile M; Smart J; Quinn P; Singh H; Gold M; Booker G; Choo S; Hii CS; Ferrante A
    Hum Mutat; 2012 Mar; 33(3):471-5. PubMed ID: 22125116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.
    Kelsen JR; Dawany N; Moran CJ; Petersen BS; Sarmady M; Sasson A; Pauly-Hubbard H; Martinez A; Maurer K; Soong J; Rappaport E; Franke A; Keller A; Winter HS; Mamula P; Piccoli D; Artis D; Sonnenberg GF; Daly M; Sullivan KE; Baldassano RN; Devoto M
    Gastroenterology; 2015 Nov; 149(6):1415-24. PubMed ID: 26193622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.